Hematology

Immunotherapy has revolutionised the treatment of haematologic malignancies. Patients with relapsed/refractory non-Hodgkin’s lymphoma have poor response…

Diagnosing cancer at an early stage is acknowledged as one of the best ways to achieve the best possible outcome for patients. With the incidence of…

Acute myeloid leukaemia (AML) is a disease with a very poor outcome and remains an area of significant unmet need, necessitating novel therapeutic…

Epstein–Barr virus (EBV) is one of the most important viral causes for the development of tumours. The global geographical epidemiology of EBV shows…

Although idiopathic aplastic anaemia (AA), myelodysplastic syndrome (MDS), and paroxysmal nocturnal haemoglobinuria (PNH) are all associated with…

Hypoxia is commonly found in a number of disorders, including cancers, alcoholism, sickle cell anaemia, and nonalcoholic fatty liver disease. The oxygen…

The European Medical Journal has published the latest edition of the EMJ Hematology eJournal. Click here to find out more